- Home
- SONO vs KOD Comparison
SONO vs KOD Comparison
Compare SONO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SONO | KOD |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | United States |
| Employees | N/A | 121 |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SONO | KOD |
|---|---|---|
| Price | $13.14 | $23.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $19.67 | ★ $28.29 |
| AVG Volume (30 Days) | ★ 1.6M | 503.1K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.60 |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $1,443,276,000.00 | N/A |
| Revenue This Year | $5.04 | N/A |
| Revenue Next Year | $6.53 | N/A |
| P/E Ratio | $18.36 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.63 | $1.92 |
| 52 Week High | $19.82 | $31.18 |
Technical Indicators
Market Signals| Indicator | SONO | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 29.95 | 41.55 |
| Support Level | $12.64 | $21.19 |
| Resistance Level | $13.94 | $29.17 |
| Average True Range (ATR) | 0.58 | 1.70 |
| MACD | -0.16 | -0.35 |
| Stochastic Oscillator | 1.01 | 8.59 |
Price Performance
Historical ComparisonAbout SONO Sonos Inc.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.